These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 32660173)

  • 1. [Research progress of immunotherapy alone and in combination for liver cancer].
    Wu ZJL; Li K; Zhang K; Gong WD
    Zhonghua Gan Zang Bing Za Zhi; 2020 Jun; 28(6):471-474. PubMed ID: 32660173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical advances in targeted therapy and immunotherapy for hepatocellular carcinoma].
    Zhang DZ; Niu JQ
    Zhonghua Gan Zang Bing Za Zhi; 2019 Nov; 27(11):834-837. PubMed ID: 31941237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Progress in immunotherapy for hepatocellular carcinoma].
    Shen Z; Li M; Bai S; Yang Q; Zhang F; Tang M; Guo J; Yang Z
    Sheng Wu Gong Cheng Xue Bao; 2019 Dec; 35(12):2326-2338. PubMed ID: 31880139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potentiality of immunotherapy against hepatocellular carcinoma.
    Tsuchiya N; Sawada Y; Endo I; Uemura Y; Nakatsura T
    World J Gastroenterol; 2015 Sep; 21(36):10314-26. PubMed ID: 26420958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Research Progresses of Targeted Therapy and Immunotherapy for Hepatocellular Carcinoma.
    Wang T; Zhang Q; Wang N; Liu Z; Zhang B; Zhao Y
    Curr Med Chem; 2021; 28(16):3107-3146. PubMed ID: 33050856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Current treatment in advanced hepatocellular carcinoma and prospects for immuno-oncology therapy].
    Xu JM
    Zhonghua Zhong Liu Za Zhi; 2017 Aug; 39(8):561-565. PubMed ID: 28835076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Liver cancer immunotherapy in the context of precision medicine].
    Huan HB; Chen XJ; Xia F
    Zhonghua Gan Zang Bing Za Zhi; 2020 Nov; 28(11):910-914. PubMed ID: 33256274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Strategies and challenges of immunotherapy for hepatocellular carcinoma].
    Zhang HH; Chen HS
    Zhonghua Gan Zang Bing Za Zhi; 2020 Jun; 28(6):457-460. PubMed ID: 32660170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Systemic therapeutic strategies for hepatocellular carcinoma: current status and prospects].
    Yuan ZG; Ye SL
    Zhonghua Gan Zang Bing Za Zhi; 2024 Jun; 32(6):565-571. PubMed ID: 38964901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Advances in the study of cellular immunotherapy for liver cancer].
    Su S; Huang XW
    Zhonghua Gan Zang Bing Za Zhi; 2020 Jun; 28(6):461-465. PubMed ID: 32660171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical immunology and immunotherapy for hepatocellular carcinoma: current progress and challenges.
    Wang L; Wang FS
    Hepatol Int; 2019 Sep; 13(5):521-533. PubMed ID: 31352593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotherapy for hepatocellular carcinoma.
    Li S; Yang F; Ren X
    Drug Discov Ther; 2015 Oct; 9(5):363-71. PubMed ID: 26632545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in non-surgical management of primary liver cancer.
    Chen X; Liu HP; Li M; Qiao L
    World J Gastroenterol; 2014 Nov; 20(44):16630-8. PubMed ID: 25469032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre- and post- operative adjuvant targeting locoregional chemotherapy combined with locoregional targeting immunostimulation and surgical resection for hepatocellular carcinoma. A new promising alternative.
    Lygidakis NJ; Konstantinidou T; Pothoulakis J
    Anticancer Res; 1994; 14(3B):1351-5. PubMed ID: 8067704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From bench to bed: the tumor immune microenvironment and current immunotherapeutic strategies for hepatocellular carcinoma.
    Fu Y; Liu S; Zeng S; Shen H
    J Exp Clin Cancer Res; 2019 Sep; 38(1):396. PubMed ID: 31500650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Current status and treatment strategies for liver injury before targeted immunotherapy for liver cancer].
    Jia JM; Ren JS; Zhang LY
    Zhonghua Gan Zang Bing Za Zhi; 2023 Nov; 31(11):1133-1136. PubMed ID: 38238945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutics for advanced hepatocellular carcinoma: Recent advances, current dilemma, and future directions.
    Zhu J; Yin T; Xu Y; Lu XJ
    J Cell Physiol; 2019 Aug; 234(8):12122-12132. PubMed ID: 30644100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current management of hepatocellular carcinoma.
    Zhou XD; Tang ZY; Yu YQ; Hou Z
    Hepatogastroenterology; 1991 Dec; 38 Suppl 1():46-55. PubMed ID: 1668377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatocellular carcinoma: Mechanisms of progression and immunotherapy.
    Jiang Y; Han QJ; Zhang J
    World J Gastroenterol; 2019 Jul; 25(25):3151-3167. PubMed ID: 31333308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress in surgical and nonsurgical approaches for hepatocellular carcinoma treatment.
    Yegin EG; Oymaci E; Karatay E; Coker A
    Hepatobiliary Pancreat Dis Int; 2016 Jun; 15(3):234-56. PubMed ID: 27298100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.